 bioavail iron hemodialysi patient erythropoietin evid inhibitori role aluminum dose recombin human erythropoietin r-huepo anemia end-stag renal diseas esrd vari patient respons r-huepo impair absolut rel iron defici exist aluminum microcyt anemia patient esrd mechan twenty-two patient canadian multicentr epo trial month random double-blind placebo-control trial free erythrocyt protoporphyrin fep indic iron-defici defici erythropoiesi relationship fep estim iron avail serum iron transferrin satur ferritin util reticulocyt count hemoglobin multipl linear regress analysi effect aluminum fep statist model variabl patient iron replet serum ferritin fep aluminum administr r-huepo aluminum treat group hemodialysi patient r-huepo proport variabl paramet iron util iron avail effect aluminum hemodialysi patient r-huepo proport variabl fep model aluminum data support hypothesi interfer bioavail store iron erythropoiesi microcyt anemia patient esrd respons r-huepo therapi